We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$451M
AUM Growth
-$16.1M
Cap. Flow
-$29.1M
Cap. Flow %
-6.45%
Top 10 Hldgs %
36.92%
Holding
175
New
4
Increased
16
Reduced
46
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$13M
2
APTV icon
Aptiv
APTV
+$8.34M
3
JPM icon
JPMorgan Chase
JPM
+$3.81M
4
ALKS icon
Alkermes
ALKS
+$2.41M
5
V icon
Visa
V
+$2.03M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.7M
2
SWN
Southwestern Energy Company
SWN
+$10.7M
3
APA icon
APA Corp
APA
+$10.6M
4
AGN
Allergan plc
AGN
+$7.65M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.27M

Sector Composition

Rank Sector Weight
1 Financials 23.48%
2 Technology 17.62%
3 Healthcare 14.5%
4 Energy 9.7%
5 Consumer Staples 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PC
151
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
$5K ﹤0.01%
465
– –
SHPG
152
DELISTED
Shire pic
SHPG
$4K ﹤0.01%
22
– –
NOK icon
153
Nokia
NOK
$52.4B
$1K ﹤0.01%
150
– –
AEP icon
154
American Electric Power
AEP
$67.2B
– –
-600
Closed -$39K
ANSS
155
DELISTED
Ansys
ANSS
– –
-400
Closed -$37K
AVGO icon
156
Broadcom
AVGO
$2T
– –
-1,200
Closed -$21K
BDX icon
157
Becton Dickinson
BDX
$49.3B
$0 ﹤0.01%
3
– –
BMY icon
158
Bristol-Myers Squibb
BMY
$132B
– –
-199,315
Closed -$10.7M
CC icon
159
Chemours
CC
$2.28B
$0 ﹤0.01%
11
– –
CNVS icon
160
Cineverse
CNVS
$65.8M
– –
-962
Closed -$39K
COP icon
161
ConocoPhillips
COP
$148B
– –
-4,000
Closed -$174K
EL icon
162
Estee Lauder
EL
$31.8B
– –
-450
Closed -$40K
MIDD icon
163
Middleby
MIDD
$5.67B
– –
-170
Closed -$21K
WAB icon
164
Wabtec
WAB
$50.6B
– –
-180
Closed -$15K
SWN
165
DELISTED
Southwestern Energy Company
SWN
– –
-770,969
Closed -$10.7M
BBBY
166
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-33,179
Closed -$1.43M
NSM
167
DELISTED
Nationstar Mortgage Holdings
NSM
– –
-6,890
Closed -$103K
SWH
168
DELISTED
Stanley Black & Decker, Inc.
SWH
– –
-2,650
Closed -$335K
ATVI
169
DELISTED
Activision Blizzard
ATVI
$0 ﹤0.01%
6
– –
GG
170
DELISTED
Goldcorp Inc
GG
– –
-1,800
Closed -$30K
PNY
171
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
– –
-600
Closed -$36K
FRP
172
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
$0 ﹤0.01%
75
– –
3 4 5 6
7

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Kelly Lawrence W & Associates held 175 positions worth $451M, down 3.4% from $467M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $29.1M in Q4 2016, closing 15 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Kelly Lawrence W & Associates opened a new position in Aptiv worth $8.36M.

  • Kelly Lawrence W & Associates's largest Q4 2016 buy was Aptiv: 124,175 shares worth $8.36M.
  • Kelly Lawrence W & Associates added most to Merck in Q4 2016, an estimated $13M increase.
  • Kelly Lawrence W & Associates's biggest Q4 2016 reduction was APA Corp, cutting an estimated $10.6M.
  • Kelly Lawrence W & Associates fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $10.7M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 37% of its $451M portfolio in Q4 2016.
  • Kelly Lawrence W & Associates opened 4 new positions and closed 15 in Q4 2016.
  • Kelly Lawrence W & Associates's portfolio value fell 3.4% quarter-over-quarter to $451M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.